Shares of IMS Health jumped Monday after a media report indicated the healthcare data firm is collecting sales offers from private-equity firms.
The Wall Street Journal reported that IMS Health is in "advanced discussions" to sell the company, possibly getting a 30% premium on shares for a value of $3.5 billion.
The stock rose 49 cents, or 2.8%, to $18.33 in after-hours trading after surging more than 21% to close at $17.84. Shares hit a 52-week high during the session.
The paper, citing people familiar with the matter, said Norwalk, Conn.-based IMS received bids late last week from private-equity firms including TPG, Silver Lake and BC Partners. A deal could be completed next month, according to the report.